Not available
Quote | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Last: | $82.22 |
---|---|
Change Percent: | 0.06% |
Open: | $82.08 |
Close: | $82.22 |
High: | $82.435 |
Low: | $81.55 |
Volume: | 1,064,271 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
2024-06-27 14:15:03 ET Scotiabank analyst issues UNDERPERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Underperform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-06-27 14:15:02 ET Wells Fargo analyst issues SECTOR PERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Sector Perform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus...
Message Board Posts | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $BMRN News Article - BioMarin Announces Advancements in FDA Review of ROCTAVIAN(TM) (Va | whytestocks | investorshangout | 11/23/2022 2:55:51 PM |
GRABAR LAW OFFICE INVESTIGATES POTENTIAL DERIVATIVE ACTION ON | jgrabar | investorshub | 04/11/2022 3:40:15 PM |
whytestocks: $BMRN News Article - Shares of BioMarin Pharmaceutical Inc. (BMRN) Rise to a New 52-Wee | whytestocks | investorshangout | 04/08/2022 5:40:51 PM |
whytestocks: $BMRN News Article - BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcrip | whytestocks | investorshangout | 10/28/2021 6:55:58 PM |
whytestocks: $BMRN News Article - European Commission Approves BioMarin's VOXZOGO (vosoritide) for t | whytestocks | investorshangout | 08/27/2021 3:05:59 PM |
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Pharmaceutical Inc. Website:
2024-06-27 14:15:03 ET Scotiabank analyst issues UNDERPERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Underperform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-06-27 14:15:02 ET Wells Fargo analyst issues SECTOR PERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Sector Perform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus...
2024-06-27 08:00:12 ET Mohit Bansal from Wells Fargo issued a price target of $115.00 for BMRN on 2024-06-27 06:54:00. The adjusted price target was set to $115.00. At the time of the announcement, BMRN was trading at $85.25. The overall price target consensus is at $110...